Avelumab for carcinoma, transitional cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Oct 2022: Trial registered, NCT05600127
  2. 1 Dec 2022: Trial started, NCT05600127

The trials

NCT05600127: Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

State
Under way
Phase
Phase 2
People
64 planned
Started
1 Dec 2022
Primary completion
Apr 2025
Arms
Avelumab
Results
None posted
  1. 31 Oct 2022: Trial registered
  2. 1 Dec 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Bavencio.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.